Jamboree/Title and Abstract

From 2013.igem.org

(Difference between revisions)

Latest revision as of 18:47, 24 October 2013

Project Title and Abstract

Due August 30

Please provide ONE project title of up to 15 words and ONE project abstract of 100 to 150 words to be included in the Jamboree program. The program will include all team projects and abstracts and will be a way to communicate what each team's project is about.

Update: You can see all the team project titles and abstracts here!

How to submit your project abstract and title

Note: The submission process for project abstracts and titles has changed! Please submit your project abstract and title using the new online system.

Log into your official team profile
Under the "Title and Abstract" section, click on "Edit" above the gray box
Enter your project title and abstract
Basic formatting utilizing the <i> and <b> HTML tags can be used

It is important that you submit your track selection on time, as the system will be closed on August 30.

Questions can be emailed to hq AT igem DOT org.

@@ Line 1: / Line 1: @@
+==Project Title and Abstract==
+<span style="font-weight:bold; font-size:110%; color:red"> Due August 30</span>
-==Title==
+Please provide ONE project title of up to '''15 words''' and ONE project abstract of '''100 to 150 words''' to be included in the Jamboree program.  The program will include all team projects and abstracts and will be a way to communicate what each team's project is about.
-<b>TestingTestingTesting</b>
+''Update:'' You can see all the team project titles and abstracts '''[https://2013.igem.org/Jamboree/Team_Abstracts here]'''!
-==Abstract==
-TESTING TESTING TESTING
-Since the discovery of penicillin by Alexander Fleming in 1928, antibiotics have marked a major victory of mankind in the battle against infectious diseases. However, after 90 years, the antibiotics are now losing their old time glory: Bacteria acquire resistance against antibiotics and become unbridled.
+====How to submit your project abstract and title====
-We must control the use of antibiotics, meanwhile, we need new antibiotics, which can suffiently eliminate the invaders without hurting the "good" bacteria. Therefore, c-di-AMP, an important, recently discovered signaling molecule in gram-positive bacteria, has come to our sight.
-Our project is to build a screening system targeting c-di-AMP, which could be applied in novel-drug screening. With this system, the level of c-di-AMP in the cell can be visualised and measured.
-==Project Abstract and Title==
-<strong>Project Title:</strong> The Beast and its Achilles Heel&#174;
 <br>
+<span style="font-weight:bold; font-size:110%; color:red">Note:</span> The submission process for project abstracts and titles has changed! Please submit your project abstract and title using the <strong>new</strong> online system.
+<html>
+<img src="https://static.igem.org/mediawiki/2013/e/e2/Team_example.png"
+         style="padding-left:15px; width:500px;">
+</html>
+# Log into your [https://igem.org/Team_List?year=2013 official team profile]
+# Under the "Title and Abstract" section, click on "Edit" above the gray box
+# Enter your project title and abstract
+# Basic formatting utilizing the &#60;i&#62; and &#60;b&#62; HTML tags can be used
-TESTING TESTING TESTING...
+It is important that you submit your track selection on time, as the system will be closed on <strong>August 30</strong>.
-<strong>Project Abstract:</strong> Since the discovery of penicillin by Alexander Fleming in 1928, antibiotics have marked a major victory of mankind in the battle against infectious diseases. However, after 90 years, the antibiotics are now losing their old time glory: Bacteria acquire resistance against antibiotics and become unbridled.
+Questions can be emailed to <strong>hq AT igem DOT org</strong>.
-We must control the use of antibiotics, meanwhile, we need new antibiotics, which can suffiently eliminate the invaders without hurting the "good" bacteria. Therefore, c-di-AMP, an important, recently discovered signaling molecule in gram-positive bacteria, has come to our sight.
-Our project is to build a screening system targeting c-di-AMP, which could be applied in novel-drug screening. With this system, the level of c-di-AMP in the cell can be visualised and measured.